Safety and Dignity Front and Center: The Opioid Epidemic in the Time of COVID-19 - On Demand Access

The opioid epidemic continues to take a punishing toll on individuals, families and communities around the country. The COVID-19 pandemic has magnified the opioid epidemic’s impact. In the face of this, oral and maxillofacial surgeons and their teams have adopted safe opioid prescribing practices. The epidemic is evolving and so must the response. This 90-minute webinar will update participants on opioid and other substance use and provide actionable steps to build on safe opioid prescribing with universal screening, reducing stigma and supporting recovery.

Learning Objectives

At the conclusion of this program, participants should be able to:

  1. Describe the evolution and current epidemiology of the opioid epidemic.
  2. Apply effective screening strategies for substance use disorder. 
  3. Identify unintentionally stigmatizing policies and practices for change.
  4. Demonstrate support for recovery from substance use. 

An Internet-based CDE/CME Activity
Original Release Date: April 27, 2021
Expiration Date: April 27, 2024
Estimated time to complete this educational activity: 1.5 hours
Method of participation: Self-Study

Melinda Campopiano von Klimo, MD

Melinda Campopiano von Klimo, MD, is board-certified in family medicine with additional credentialing in addiction medicine. She practiced primary care and addiction medicine for 10 years in urban and rural settings, integrating primary care and behavioral health. She has led a family medical practice, served as Medical Director of opioid treatment programs (OTPs) and treated patients with buprenorphine in an office-based setting. As a Medical Officer at Substance Abuse and Mental Health Services Administration (SAMHSA) for five years, Dr. Campopiano had regulatory authority for OTPs, updated the federal guidelines for OTPs and wrote new regulations expanding access to buprenorphine. As Senior Medical Advisor at JBS International, she applies clinical experiences and policy and implementation expertise across projects for federal agencies (such as the Health Resources and Services Administration, National Institute on Drug Abuse, SAMHSA, Administration for Children and Families and Department of Justice), states and other organizations (such as the American Society of Addiction Medicine and American Academy of Pediatrics).  


Faculty and Planner Disclosure
3 Questions  |  1 attempt  |  0/3 points to pass
3 Questions  |  1 attempt  |  0/3 points to pass
Safety and Dignity Front and Center: The Opioid Epidemic in the Time of COVID-19
Open to view video.
Open to view video.
3 Questions  |  Unlimited attempts  |  2/3 points to pass
3 Questions  |  Unlimited attempts  |  2/3 points to pass
11 Questions
1.50 CDE/CME credits  |  Certificate available
1.50 CDE/CME credits  |  Certificate available